Position in ALLO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,798,328
+$3,054,715 QoQ
Shares Held
4,710,735
+70.4% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 209 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. ALLO ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ALLO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,798,328 | 4,710,735 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,743,613 | 2,763,776 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,757,670 | 1,282,971 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $575,233 | 463,898 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $116,120 | 54,517 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $252,910 | 90,325 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $559,793 | 240,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $875,127 | 195,778 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $242,804 | 75,640 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $393,834 | 124,238 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,370,964 | 275,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,532,619 | 512,676 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,152,575 | 660,187 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,748,706 | 439,695 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,234,077 | 283,691 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,974,288 | 985,103 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,904,839 | 529,815 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $583,595 | 22,708 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,275,019 | 202,263 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $243,568 | 6,459 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||